Clinical trial
SORINT - SORafenib for Treatment of Patients With INTermediate Stage Hepatocellular Carcinoma
NCT01908322 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SORINT - SORafenib for Treatment of Patients With INTermediate Stage Hepatocellular Carcinoma
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- September 30, 2015
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.